Sentiment-Signal
25,2
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 03.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; App |
Stammdaten
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
Unternehmen & Branche
| Name | Privia Health Group, Inc. |
|---|---|
| Ticker | PRVA |
| CIK | 0001759655 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
| SIC | 8000 · Services-Health Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 3,08 Mrd. USD |
| Beta | 0,87 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 22,919,000 | 0.18 | 1,369,378,000 | 737,217,000 | |
| 2025-09-30 | 10-Q | 6,861,000 | 0.05 | 1,350,987,000 | 709,124,000 | |
| 2025-06-30 | 10-Q | 2,687,000 | 0.02 | 1,272,542,000 | 682,855,000 | |
| 2025-03-31 | 10-Q | 4,220,000 | 0.03 | 1,183,538,000 | 659,436,000 | |
| 2024-12-31 | 10-K | 14,385,000 | 0.11 | 1,135,783,000 | 635,183,000 | |
| 2024-09-30 | 10-Q | 3,535,000 | 0.03 | 1,145,565,000 | 614,886,000 | |
| 2024-06-30 | 10-Q | 3,467,000 | 0.03 | 1,077,621,000 | 595,407,000 | |
| 2024-03-31 | 10-Q | 2,984,000 | 0.02 | 1,031,586,000 | 576,800,000 | |
| 2023-12-31 | 10-K | 23,079,000 | 0.19 | 999,900,000 | 561,437,000 | |
| 2023-09-30 | 10-Q | 5,643,000 | 0.05 | 992,330,000 | 544,681,000 | |
| 2023-06-30 | 10-Q | 7,274,000 | 0.06 | 937,574,000 | 525,232,000 | |
| 2023-03-31 | 10-Q | 7,324,000 | 0.06 | 875,343,000 | 513,276,000 | |
| 2022-12-31 | 10-K | -8,585,000 | -0.08 | 792,813,000 | 499,094,000 | |
| 2022-09-30 | 10-Q | 1,624,000 | 0.01 | 807,786,000 | 470,186,000 | |
| 2022-06-30 | 10-Q | -10,475,000 | -0.10 | 744,990,000 | 445,155,000 | |
| 2022-03-31 | 10-Q | -17,510,000 | -0.16 | 723,183,000 | 435,042,000 | |
| 2021-12-31 | 10-K | -188,230,000 | -1.83 | 686,373,000 | 426,872,000 | |
| 2021-09-30 | 10-Q | -9,115,000 | -0.09 | 632,061,000 | 410,600,000 | |
| 2021-06-30 | 10-Q | -172,534,000 | -1.68 | 597,139,000 | 393,300,000 | |
| 2021-03-31 | 10-Q | 5,398,000 | 0.06 | 348,276,000 | 152,247,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -5,566 | 20.85 | -116,051.10 | -39,7% | |
| 2026-03-16 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -6,391 | 22.11 | -141,305.01 | -48,4% | |
| 2026-03-16 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -26,509 | 22.11 | -586,113.99 | -200,8% | |
| 2026-03-13 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -27,229 | 21.52 | -585,968.08 | -200,7% | |
| 2026-03-13 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -6,565 | 21.52 | -141,278.80 | -48,4% | |
| 2026-03-12 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -26,763 | 21.90 | -586,109.70 | -200,7% | |
| 2026-03-12 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -6,453 | 21.90 | -141,320.70 | -48,4% | |
| 2026-03-10 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -21,097 | 22.71 | -479,112.87 | -164,1% | |
| 2026-03-09 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -1,219 | 23.37 | -28,488.03 | -9,8% | |
| 2026-03-09 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -18,865 | 22.84 | -430,876.60 | -147,6% | |
| 2026-03-09 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -21,915 | 22.84 | -500,538.60 | -171,4% | |
| 2026-03-09 | Fargis Edward C | Officer, EVP & General Counsel | Open Market Sale | -4,949 | 22.84 | -113,035.16 | -38,7% | |
| 2026-03-09 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -5,829 | 22.84 | -133,134.36 | -45,6% | |
| 2026-03-06 | Fargis Edward C | Officer, EVP & General Counsel | Open Market Sale | -4,394 | 23.15 | -101,721.10 | -34,8% | |
| 2026-03-06 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -21,440 | 23.15 | -496,336.00 | -170,0% | |
| 2026-03-06 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -5,177 | 23.15 | -119,847.55 | -41,0% | |
| 2026-02-27 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -7,697 | 25.05 | -192,809.85 | -66,0% | |
| 2026-02-27 | Morris Matthew Shawn | Director | Open Market Sale | -16,550 | 25.00 | -413,750.00 | -141,7% | |
| 2026-02-26 | Morris Matthew Shawn | Director | Open Market Sale | -7,788 | 24.99 | -194,622.12 | -66,7% | |
| 2026-02-26 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -5,361 | 25.00 | -134,025.00 | -45,9% | |
| 2025-12-12 | Morris Matthew Shawn | Director | Open Market Sale | -13,647 | 25.01 | -341,311.47 | -116,9% | |
| 2025-12-12 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -23,887 | 25.03 | -597,891.61 | -204,8% | |
| 2025-05-13 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -15,909 | 24.52 | -390,088.68 | -133,6% | |
| 2025-05-12 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -13,773 | 24.99 | -344,187.27 | -117,9% | |
| 2025-05-12 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -3,322 | 24.99 | -83,016.78 | -28,4% | |
| 2025-05-01 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -17,365 | 23.08 | -400,784.20 | -137,3% | |
| 2025-04-30 | Mountcastle David | Officer, EVP & Chief Financial Officer | Open Market Sale | -3,445 | 23.33 | -80,371.85 | -27,5% | |
| 2025-04-30 | Mehrotra Parth | Director, Officer, Chief Executive Officer | Open Market Sale | -15,100 | 23.33 | -352,283.00 | -120,7% | |
| 2025-04-30 | Morris Matthew Shawn | Director | Open Market Sale | -10,309 | 23.33 | -240,508.97 | -82,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.